Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Antex evaluates dosing schedule in phase Ib/II trial of Helivax

July 28, 2000

Antiviral action of aciclovir lipid prodrug assessed against woodchuck hepatitis virus

July 28, 2000

Salix's Colazal approved in U.S. for ulcerative colitis

July 27, 2000

Antiinflammatory profile of ridogrel examined in inflamed colorectal mucosal biopsies

July 27, 2000

New hepatitis C treatment reaches market simultaneously in two European countries

July 24, 2000

Z-338 characterized for pharmacokinetics and safety after single and multiple doses

July 24, 2000

Yamanouchi presents new quinolones with useful activity against H. pylori

July 19, 2000

CPT 2000 highlights: greater AUC results in greater acid inhibition with esomeprazole

July 19, 2000

Ribavirin analogue ICN-17261 may have therapeutic advantages over ribavirin in HCV

July 19, 2000

Santarus initiates phase II trial of delayed-release azathioprine for treatment of Crohn's disease

July 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...